Dr. Ruchi Bansal research entitled “CD64-Targeted Prednisolone Lipid Nanoparticles As a Novel Drug Delivery System to Target Inflammatory Macrophages for the Treatment of Alcoholic Liver Diseases” was selected for oral presentation, young investigator award and highlighted as “The Best of the Liver Meeting 2018”.
28 Nov 2018
Degree of recognition
American Association for the Study of Liver Diseases (AASLD)
Awarded at event
Liver Meeting 2018
Moscone North and South Convention Center, San Francisco, United States